AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Noninvasive Artificial Venous Stasis for Reperfusion in STEMI

Recruitingn/aAges 18 Years - 80 YearsAllFirat University
💬

In plain words

What the trial is, and whether it could suit you

This prospective, randomized study was designed to evaluate whether the noninvasive artificial venous stasis / RE-START procedure, administered prior to primary percutaneous coronary intervention, increases the frequency of spontaneous coronary reperfusion in the infarct-related artery.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Having presented within the first 12 hours of symptom onset Being hemodynamically stable (Killip Class I-II) * STEMI diagnosis confirmed by coronary angiography * Primary PCI (percutaneous coronary intervention) scheduled * No pathology in the upper extremity that would prevent cuff application * Be capable of providing informed consent and provide consent Exclusion Criteria: * Presence of cardiogenic shock (systolic blood pressure \< 90 mmHg and Killip Class III-IV) * Cardiac arrest occurring before or after the procedure * Need for resuscitation following failed thrombolysis * History of prior coronary artery bypass surgery * Concurrent acute aortic dissection * Venous thromboembolism or pulmonary embolism * History of an acute infection within the past 7 days * Chronic kidney disease requiring erythropoietin therapy or currently undergoing hemodialysis * Presence of liver failure or a hematologic disorder * Presence of any chronic inflammatory or autoimmune disease * History of any known malignancy (cancer) * Current treatment with glibenclamide, corticosteroids, antioxidant vitamins, or cyclosporine at the time of enrollment * History of chronic (daily) alcohol consumption * Contraindications to aspirin and/or clopidogrel * Failure to confirm a STEMI diagnosis via coronary angiography * Inability to provide informed consent * Pregnancy * First 6 months postpartum Conditions in which the administration of thrombolytics is contraindicated
💊

What it tests

  • Not listed
📍

Where

2 sites
Firat University
Elâzığ, Turkey (Türkiye)
Firat University
Elâzığ, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy